Media coverage
1
Media coverage
Title Aeglea BioTherapeutics Announces New Positive Phase 1/2 Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 Annual Meeting of the Society for Inherited Metabolic Disorders Media name/outlet Spoke.com Country/Territory United States Date 8/04/19 URL www.spoke.com/press_releases/5caa921c2c73fffcd9009b4a Persons George Diaz